Locomotor ataxia
Locomotor Ataxia is a medical condition characterized by the loss of full control of bodily movements. It is also known as Tabes dorsalis, a late manifestation of untreated syphilis that affects the dorsal columns of the spinal cord and the peripheral nerves.
Symptoms[edit]
The symptoms of Locomotor Ataxia include difficulty in walking, impaired sense of vibration and position, and loss of reflexes. Other symptoms may include Charcot's joints, shooting pain, and changes in vision.
Causes[edit]
Locomotor Ataxia is caused by the degeneration of the dorsal columns of the spinal cord, which are responsible for carrying information about touch and proprioception. This degeneration is a result of untreated syphilis, a sexually transmitted infection caused by the bacterium Treponema pallidum.
Diagnosis[edit]
The diagnosis of Locomotor Ataxia is based on the patient's medical history, physical examination, and specific diagnostic tests. These tests may include a lumbar puncture to examine the cerebrospinal fluid and blood tests to detect the presence of the Treponema pallidum bacterium.
Treatment[edit]
The treatment for Locomotor Ataxia involves managing the symptoms and treating the underlying syphilis infection. This may include the use of antibiotics, pain management, and physical therapy to help improve mobility and muscle strength.
Prognosis[edit]
The prognosis for individuals with Locomotor Ataxia varies. With early diagnosis and treatment, the progression of the disease can be slowed and some symptoms can be managed effectively.
See also[edit]
-
Nude man with locomotor ataxia walking
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
